Pharmacological targeting of TNS3 with histone deacetylase inhibitor as a therapeutic strategy in esophageal squamous cell carcinoma

被引：5
|
作者：
Shi, Yang [1 ,2 ]
Xiang, Zheng [4 ]
Yang, Huiyu [1 ,2 ]
Khan, Suliman [5 ]
Li, Ruizhe [3 ]
Zhou, Siran [1 ,2 ]
Ullah, Saif [1 ,2 ]
Zhang, Jiyu [1 ,2 ]
Liu, Bingrong [1 ,2 ]
机构：
[1] Zhengzhou Univ, Dept Gastroenterol, Affiliated Hosp 1, Zhengzhou 450052, Peoples R China
[2] Zhengzhou Univ, State Key Lab Esophageal Canc Prevent & Treatment, Zhengzhou 450052, Peoples R China
[3] Zhengzhou Univ, Affiliated Hosp 1, Dept Pathol, Zhengzhou 450052, Peoples R China
[4] Zhengzhou Univ, Henan Univ, Henan Prov Peoples Hosp, Dept Pathol,Peoples Hosp, Zhengzhou 450003, Peoples R China
[5] Zhengzhou Univ, Affiliated Hosp 2, Dept Cerebrovasc Dis, Zhengzhou 450000, Peoples R China
来源：
AGING-US | 2021年 / 13卷 / 11期
基金：
中国国家自然科学基金;
关键词：
histone deacetylase inhibitors; LMK-235; esophageal squamous cell carcinoma; tensin-3; histone acetylation; SRC FAMILY KINASES; HDAC INHIBITORS; PROTEIN; EPIGENETICS; COMBINATION; EXPRESSION; PACKAGE;
D O I：
10.18632/aging.203091
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
Histone acetylation which regulates about 2-10% of genes has been demonstrated to be involved in tumorigenesis of esophageal squamous cell carcinoma (ESCC). In this study, we investigated the treatment response of ESCC to selective histone deacetylase inhibitor (HDACi) LMK-235 and potential biomarker predicting the treatment sensitivity. We identified tensin-3 (TNS3) which was highly over-expressed in ESCC as one of the down-regulated genes in response to LMK-235 treatment. TNS3 was found positively correlated with the tumor malignancy and poor prognosis in the patients. Silencing TNS3 significantly inhibited ESCC cell proliferation both in vitro and in vivo, sensitizing the treatment response to LMK-235. Our findings provide an insight into understanding the oncogenic role of TNS3 in ESCC and its clinical application for HDAC targeted therapy of ESCC.
引用
收藏
页码：15336 / 15352
页数：17
相关论文
共 50 条
  • [21] Targeting Histone Deacetylase-7 as a Novel Therapeutic Strategy for Glioblastoma Multiforme
    Hassan, Ola
    Karambizi, David
    Tapinos, Nikos
    FASEB JOURNAL, 2022, 36
  • [22] The identification of the ATR inhibitor VE-822 as a therapeutic strategy for enhancing cisplatin chemosensitivity in esophageal squamous cell carcinoma
    Shi, Qi
    Shen, Lu-Yan
    Dong, Bin
    Fu, Hao
    Kang, Xiao-Zheng
    Yang, Yong-Bo
    Dai, Liang
    Yan, Wan-Pu
    Xiong, Hong-Chao
    Liang, Zhen
    Chen, Ke-Neng
    CANCER LETTERS, 2018, 432 : 56 - 68
  • [23] Therapeutic Potential of Antibody Targeting Neuronal Pentraxin Receptor in Esophageal Squamous Cell Carcinoma
    Shinozuka, Takahiro
    Kanda, Mitsuro
    Sato, Yusuke
    Shimizu, Dai
    Umeda, Shinichi
    Takami, Hideki
    Hattori, Norifumi
    Hayashi, Masamichi
    Tanaka, Chie
    Kodera, Yasuhiro
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (09) : 5674 - 5682
  • [24] CpG dinucleotide-specific hypermethylation of the TNS3 gene promoter in human renal cell carcinoma
    Carter, Jessica A.
    Gorecki, Dariusz C.
    Mein, Charles A.
    Ljungberg, Borje
    Hafizi, Sassan
    EPIGENETICS, 2013, 8 (07) : 739 - 747
  • [25] EIF4A3-mediated oncogenic circRNA hsa_circ_0001165 advances esophageal squamous cell carcinoma progression through the miR-381-3p/TNS3 pathway
    Zhang, Xun
    Bian, Yan
    Li, Qiuxin
    Yu, Chuting
    Gao, Ye
    Tian, Bo
    Xia, Wenqiang
    Wang, Wei
    Xin, Lei
    Lin, Han
    Wang, Luowei
    CELL BIOLOGY AND TOXICOLOGY, 2024, 40 (01)
  • [26] The anti-tumor effects of dual PI3K/mTOR inhibitor BEZ235 and histone deacetylase inhibitor Trichostatin A on inducing autophagy in esophageal squamous cell carcinoma
    Wu, Ning
    Zhu, Yingfeng
    Xu, Xiao
    Zhu, Yongjun
    Song, Yang
    Pang, Liewen
    Chen, Zhiming
    JOURNAL OF CANCER, 2018, 9 (06): : 987 - 997
  • [27] Aberrant expression of histone deacetylase 6 in oral squamous cell carcinoma
    Sakuma, Takumi
    Uzawa, Katsuhiro
    Onda, Takeshi
    Shiiba, Masashi
    Yokoe, Hidetaka
    Shibahara, Takahiko
    Tanzawa, Hideki
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2006, 29 (01) : 117 - 124
  • [28] Oncogenic IL7R is downregulated by histone deacetylase inhibitor in esophageal squamous cell carcinoma via modulation of acetylated FOXO1
    Kim, Myoung Jun
    Choi, Sung Kyung
    Hong, Seong Hwi
    Eun, Jung Woo
    Nam, Suk Woo
    Han, Jeung-Whan
    You, Jueng Soo
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2018, 53 (01) : 395 - 403
  • [29] Targeting histone deacetylases in head and neck squamous cell carcinoma: molecular mechanisms and therapeutic targets
    Xu, Mengchen
    Hou, Yiming
    Li, Na
    Yu, Wenqian
    Chen, Lei
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [30] Targeting the LSD1-G9a-ER Stress Pathway as a Novel Therapeutic Strategy for Esophageal Squamous Cell Carcinoma
    Wang, Hongxiao
    Song, Zijun
    Xie, Enjun
    Chen, Junyi
    Tang, Biyao
    Wang, Fudi
    Min, Junxia
    RESEARCH, 2022, 2022
12345